Navigation Links
Predictive Biomarker Discovery for Oncology Small-Molecules and Biologics - a Webinar Hosted by Xtalks
Date:5/9/2013

Toronto, Canada (PRWEB) May 09, 2013

Recent advances in next-generation sequencing technologies are revolutionizing the way human disease is defined, providing avenues to develop novel, individualized therapies that target the genomic underpinnings of a patient’s condition. No disease has been more directly impacted by this than cancer, which is fundamentally a disorder of acquired somatic alterations.

Dr. Jameel Shah, Principal Scientist and Group Leader of Oncology at Eurofins Panlabs will speak about the Integration of High-Content Cell Line Profiling and Univariate Genomics Analysis to Discover and Prioritize Predictive Biomarkers in Oncology. Several examples will be discussed in this webinar to illustrate the predictive power of this approach to identify biomarkers of response.

Co-speaker DR. Jonathan Crane, Senior Scientist of Oncology and Cell Biology at Eurofins Panlabs will discuss High-content Live-cell Imaging Analysis of Therapeutic Monoclonal Antibody Binding and Potency Across 240 Genomically Defined Cancer Cell Lines. This presentation will describe the high-throughput parallelization of quantitative, comparative therapeutic antibody binding measurements and drug response profiling data by new high-content imaging.

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit:
http://www.xtalks.com/OncoPanel-cell-line-profiling-and-imaging-analysis.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10704346.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type
2. Data mining opens the door to predictive neuroscience
3. Eaton Apothecary Selects Predictive Acquisition Cost (PAC) Drug Price Type
4. GNS Healthcare Joins Orion Bionetworks to Develop Predictive Models for Multiple Sclerosis and Other Diseases
5. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
6. Biomarkers - Technologies, Markets and Companies
7. Use Biomarkers in Alzheimers Disease Clinical Trials, Says Expert Group
8. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
9. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
10. MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016
11. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... and PETACH TIKVAH, ... -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a ... for neurodegenerative diseases, announced financial results for ... "2016 was a highly successful and ... achievements and significant progress made on clinical, ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, Inc. ... and drug-delivery therapies, today announced that an Oncologic ... Drug Administration voted 11 to 0 that the ... injection was favorable for patients in the proposed ... and chronic lymphocytic leukemia. The FDA action date ...
(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... Bactana ... and hormones in the world’s food supply through enhancement of the gut microbiota, today ... round included Connecticut Innovations , New York-based Sustainable Income Capital Management, LLC and ...
(Date:3/29/2017)... March 29, 2017 /PRNewswire/ -  GeneNews Limited (TSX:GEN) ("GeneNews" ... , a new risk stratification test for breast cancer, via ... Diagnostics Laboratory ("IDL"). BreastSentry incorporates a blood-based biomarker test with ... risk for developing breast cancer.   ... BreastSentry measures the fasting plasma ...
Breaking Biology Technology:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
Breaking Biology News(10 mins):